On Tuesday, the Food and Drug Administration issued a warning about certain direct-acting antiviral drugs used to treat hepatitis C. The drugs can reactivate the hepatitis B virus in patients ...

Hepatitis C virus treatment is increasingly being offered in primary care because medications now require less frequent monitoring and have fewer adverse effects.

Understanding what hepatitis C is, how it spreads and how it is treated can replace fear with clarity.

Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the illness. Patients with moderate to severe ...

(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...

Editor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded indication to treat acute HCV. Glecaprevir, one of the two DAAs in Mavyret, was Discovered ...

SAN FRANCISCO — Medicaid programs in Delaware, Maryland, New Jersey, and Pennsylvania denied nearly half of all claims in recent months for direct-acting antiviral hepatitis C drugs, according to an ...

Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to the Albany Daily Star. 1. The increase in spending will raise the insurance ...

Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...

New national hepatitis elimination profiles reveal policy and implementation gaps in reaching global viral hepatitis elimination targets.